- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
Caring Brands, Inc. Common Stock(CABR)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for CABR
11/13/2026: CABR (1-star) is currently NOT-A-BUY. Pass it for now.
Caring Brands, Inc. is a micro-cap wellness consumer products company offering specialized over-the-counter and cosmetic remedies for hair loss, eczema, psoriasis, and skin protection. The company's primary business strengths include a portfolio of patented formulations and an asset-light licensing model that expands its international footprint. Its core investment story centers on scaling high-margin royalty streams and expanding product lines into new wellness categories like nausea relief. However, investors must weigh significant risks, including early-stage operating losses, heavy reliance on private placements for capital, and intense competition from large pharmaceutical conglomerates. The stock is suited primarily for speculative or growth-oriented investors willing to accept high volatility while monitoring ongoing cash burn, licensing developments, and capital-raising milestones.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | While percentage revenue expansion is rapid from a minuscule base, execution and scaling risks remain substantial. |
| Momentum investor | Strong fit while signal remains positive | The stock can exhibit sharp short-term price movements and high volume spikes driven by news flow and capital placement events. |
| Value investor | Weak fit | Negative earnings and early-stage cash burn make traditional value metrics inapplicable. |
| Dividend investor | Weak fit | The company pays no dividends, focusing entirely on cash preservation and operational deployment. |
| Low-risk investor | Weak fit | High share price volatility, micro-cap liquidity profile, and recurring losses expose investors to significant downside risk. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | Low market capitalization and intermittent trading volume can trigger rapid price swings. |
| Valuation risk | High | Pricing is largely sentiment-driven due to minimal baseline earnings and early revenue stages. |
| Competition risk | High | Large healthcare and cosmetic conglomerates dominate market shelf space and distribution. |
| Business quality | Medium / high | The firm relies heavily on niche patented formulations and third-party licensing agreements. |
| Dividend income | Low / none | No payouts are distributed to shareholders. |
| Execution risk | High | Success depends entirely on commercializing product pipelines and securing ongoing funding. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 8.42M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 107.3K shares | Beta - | 52 Weeks Range 0.60 - 1.84 | Updated Date 11/15/2026 |
52 Weeks Range 0.60 - 1.84 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.78 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Drug Manufacturers - Specialty & Generic
- BUY participation
- 66.7%
- Active BUY / eligible
- 8 / 12
- 30-Day BUY Count Change
- +3
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Rolling Over
The price momentum is slowing down and beginning to turn downward.

Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit -26.23% | Avg. Invested days 21 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Over-the-Counter & Cosmetic Product Sales | Direct sales of specialized wellness, hair care, and dermatological formulations such as Hair Enzyme Booster and Photocil. | The company sells niche health and skin products directly to consumers and distributors. |
| Licensing Royalties | Multi-territory licensing agreements granting third-party manufacturers the right to market products abroad. | Caring Brands earns licensing fees from partners who sell its patented products in international markets. |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 6.15M | Price to Sales(TTM) 7267.24 |
Enterprise Value 6.15M | Price to Sales(TTM) 7267.24 | ||
Enterprise Value to Revenue 5303.4 | Enterprise Value to EBITDA - | Shares Outstanding 10.47M | Shares Floating 2.34M |
Shares Outstanding 10.47M | Shares Floating 2.34M | ||
Percent Insiders 25.82 | Percent Institutions 2.45 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

